A phase II study of lapatinib and dose-dense temozolomide (TMZ) for adults with recurrent ependymoma: Patient reported putcomes (PRO) from a CERN clinical trial Meeting Abstract
| Authors: | Armstrong, T. S.; Vera-Bolanos, E.; Gilbert, M.; Yuan, Y.; Wani, K.; Wu, J. M.; Omuro, A.; Lieberman, F.; Robins, H. I.; Gerstner, E.; Wu, J.; Wen, P.; Mikkelsen, T.; Aldape, K.; Mendoza, T. |
| Abstract Title: | A phase II study of lapatinib and dose-dense temozolomide (TMZ) for adults with recurrent ependymoma: Patient reported putcomes (PRO) from a CERN clinical trial |
| Meeting Title: | 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 16 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2014 Nov 13-16 |
| Meeting Location: | Miami, FL |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-11-01 |
| Start Page: | v9 |
| Language: | English |
| ACCESSION: | WOS:000350452200037 |
| DOI: | 10.1093/neuonc/nou237.7 |
| PROVIDER: | wos |
| PMCID: | PMC4217844 |
| Notes: | Meeting Abstract: AT-07 -- Source: Wos |
